- Home
- UCL vs VRCA Comparison
UCL vs VRCA Comparison
Compare UCL & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCL
- VRCA
- Stock Information
- Founded
- UCL 2014
- VRCA 2013
- Country
- UCL Hong Kong
- VRCA United States
- Employees
- UCL N/A
- VRCA N/A
- Industry
- UCL Telecommunications Equipment
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- UCL Consumer Discretionary
- VRCA Health Care
- Exchange
- UCL Nasdaq
- VRCA Nasdaq
- Market Cap
- UCL 65.9M
- VRCA 54.0M
- IPO Year
- UCL 2020
- VRCA 2018
- Fundamental
- Price
- UCL $1.83
- VRCA $0.58
- Analyst Decision
- UCL
- VRCA Hold
- Analyst Count
- UCL 0
- VRCA 5
- Target Price
- UCL N/A
- VRCA $6.00
- AVG Volume (30 Days)
- UCL 96.8K
- VRCA 254.0K
- Earning Date
- UCL 08-13-2025
- VRCA 08-13-2025
- Dividend Yield
- UCL N/A
- VRCA N/A
- EPS Growth
- UCL N/A
- VRCA N/A
- EPS
- UCL 0.09
- VRCA N/A
- Revenue
- UCL $92,256,000.00
- VRCA $7,179,000.00
- Revenue This Year
- UCL $6.09
- VRCA $171.87
- Revenue Next Year
- UCL $7.01
- VRCA $71.38
- P/E Ratio
- UCL $19.83
- VRCA N/A
- Revenue Growth
- UCL 7.65
- VRCA N/A
- 52 Week Low
- UCL $0.80
- VRCA $0.38
- 52 Week High
- UCL $3.30
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- UCL 61.19
- VRCA 49.82
- Support Level
- UCL $1.75
- VRCA $0.60
- Resistance Level
- UCL $2.27
- VRCA $0.71
- Average True Range (ATR)
- UCL 0.15
- VRCA 0.07
- MACD
- UCL -0.01
- VRCA -0.00
- Stochastic Oscillator
- UCL 42.99
- VRCA 43.69
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.